Skip to main content
Fig. 3 | Cardiovascular Diabetology

Fig. 3

From: Time-resolved trajectory of glucose lowering medications and cardiovascular outcomes in type 2 diabetes: a recurrent neural network analysis

Fig. 3

Attention landscapes associated with 4P-MACE components. Each panel shows the average attention profile associated with the respective outcome, normalised trimester by trimester. The X axis represents time in months as a negative offset to event or exit time; the Y axis represents the input variable (age, sex, diabetes duration, or GLM ATCs); the Z axis is the normalised average attention matrix across all training subjects. The variables with the most varied attention landscapes for each outcome are highlighted via solid polygons. A10BB09, gliclazide. A10BB12, glimepiride. A10BA02, metformin. A10BD02, metformin and sulfonylureas. A10AE04, insulin glargine

Back to article page

Cardiovascular Diabetology

ISSN: 1475-2840